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Abstract
In this chapter, we review the recent developments, including our studies on the micro‐
fabricated devices applicable to stem cell culture. We will focus on the application of plu‐
ripotent stem cells including embryonic stem cells and induced pluripotent stem cells. In
the first section, we provide a background on microfluidic devices, including their fabri‐
cation technology, characteristics, and the advantages of their application in stem cell cul‐
ture. The second section outlines the use of micropatterning technology in stem cell
culture. The use of microwell array technology in stem cell culture is explored in the third
section. In the fourth section, we discuss the use of the microfluidic perfusion culture sys‐
tem for stem cell culture, and the last section is a summary of the current state of the art
and perspectives of microfluidic technologies in stem cell culture.
Keywords: Embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, microfluidic
perfusion culture, micropatterning, microwell array
1. Introduction
This section provides a general background on microfluidic devices and explains the general
microfabrication technologies applicable to stem cell culture including embryonic stem (ES)
cells  and induced pluripotent stem (iPS)  cells.  We will  discuss the importance of  small-
scale patterning, three-dimensional structure, and medium flow in terms of microenviron‐
ment control and the importance of small volumes, in terms of research cost, for industrial
application.
1.1. Microfabrication technology available for stem cell culture
Microfabrication technology progressed rapidly with the development of semiconductor
industry in the 20th century. By the end of the 20th century, the application of microfabrication
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technology started to grow in different research areas including biotechnology. In biotechnol‐
ogy, microfabrication technology was initially used for molecular analyses of DNA and
proteins and gradually its application diversified to cell culture. This technology enabled
precise fabrication of structures with sizes as small as submicrometer, replication of the
fabricated structure, liquid manipulation in very small volumes, portability of the devices, and
usage of small amounts of expensive reagents. Owing to these advantages, microfabrication
technology is expected to create new applications in the cell culture including stem cells.
Many types of materials, including inorganic materials, metals, polymers, and plastics, are
applicable to microfabrication. Silicon and glass have been used to fabricate microstructures
and semiconductor devices [1, 2]. Polydimethylsiloxane (PDMS), a silicone elastomer, is the
most popular material used for the fabrication of microfluidic cell culture devices due to the
ease of fabrication, optical transparency, gas permeability, low chemical reactivity, and
inexpensiveness. In addition, microstructure of PDMS is generally fabricated by soft lithog‐
raphy in a few days [3]. This easy and quick process broadens the use of microfluidic devices
in cell culture applications. In soft lithography process, replica of microstructure in PDMS can
be repeatedly fabricated from a microstructure of photoresist that is originally made using
photolithography [4, 5]. A multilayered microstructure of PDMS can also be fabricated by
using multilayered photoresist pattern [6, 7]. Details of the fabrication method used for soft
lithography have been described in previous studies [3, 8]. Many biologists are currently using
this convenient microfabrication technology.
Soft lithography is a convenient method for fabricating microstructures on a laboratory scale.
Scientists can fabricate dozens of microfluidic devices by themselves for their research.
However, for industrial applications, hundreds or thousands of microfluidic devices are
required. In addition, it is known that PDMS absorb small hydrophobic molecules [9].
Therefore, other materials applicable to mass production and capable of avoiding molecular
adsorption are desired for the industrial application of microfluidic devices. Low-cost
fabrication technologies such as injection molding [10, 11] and rapid prototyping [12, 13] are
promising fabrication technologies that can address the above-mentioned issues.
In addition, cell culture often requires extracellular matrixes (ECMs). Therefore, microfabri‐
cation of biomaterials, such as hydrogel, is of interest to biologists and engineers. Photofabri‐
cated hydrogels have been studied extensively to create microstructure in the hydrogels [14].
These microfabricated hydrogels have been used for tissue engineering.
1.2. Characteristics of microfabricated cell culture device
Significant features that affect a microfluidic device are flow viscosity, interfacial tension,
laminar flow, fast diffusion, etc. [15]. The characteristic flow profile enabled the formation of
special microenvironment including chemical [16] and temperature gradients [17]. Also, a
microfluidic perfusion culture continuously supplies nutrient and removes waste, and
therefore keeps the culture condition more stable and constant compared with a static cell
culture [18]. Furthermore, a microfluidic perfusion culture potentially provides new oppor‐
tunities for cell culture applications because of the precise control of the microscale environ‐
ment [19–22]. For example, some cell types, such as endothelial cells, are sensitive to shear
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stress caused by the flow of the medium [23]. Another example, in 3D culture condition, such
as spheroid culture, molecular transport in the microchannels can be controlled by convection
flow and the controlled molecular transport affects the state of inner cells in the spheroids [24].
Therefore, microfluidic perfusion culture can be used for both fundamental research and drug
development.
Another feature of cell culture in microfluidic device is its small volume. The miniaturized
assays are expected to increase experimental throughput and reliability for drug discovery
applications [25–27]. This is an important aspect for the application of microfluidic technology
to stem cell culture because culturing stem cells, especially human iPSCs, is cost-prohibitive
[28]. Microfluidic systems are cost-effective because these systems need small quantity of
culture medium and reagents.
In addition, microfluidic device can generate many cell culture conditions using microfluidic
network. For example, we have developed a microfluidic network to generate step-wise serial
dilutions [29]. We also reported the method to fabricate combinatorial microenvironment array
on a microfluidic device [30]. Titmarsh et al. reported a microfluidic network to generate
combinatorial array of culture conditions composed of multiple soluble factors at different
concentrations [31], and applied this device for the analysis of human embryonic stem cell
culture conditions. We think these examples are just the beginning of the application of
microfabrication technology in stem cell culture. Possibly, there are additional scopes for
applications because many unknown phenomena regarding stem cell culture are yet to be
understood.
1.3. Control of cell culture microenvironment
Conventionally, cell culture has been carried out in Petri dishes as static culture. In Petri dishes,
the actively growing cells form monolayer sheet and culture media is placed on the cells. In
this static monolayer culture, cells grow at randomly arranged positions and medium is
exchanged regularly in batches. The stem cells are cultured in a similar manner. In contrast,
cells in our bodies form highly ordered 3D microstructures and respond to their surrounding
microenvironments including soluble factors, ECMs, contact-dependent intercellular signals,
and mechanical signals. Therefore, the 3D nature of native, complex microenvironments is not
accurately recapitulated in traditional cell culture on Petri dishes[32]. Microfabrication
technology has the potential to control the parameters to simulate these complex 3D micro‐
environments.
2. Micropatterning technology in stem cell culture
Monolayer cultures of stem cells garnered considerable attention after human ES/iPS cells were
established, because these cells are cultured as a monolayer colony and cannot survive without
adhering to the surface of the culture dish. In addition, the differentiation of these cells is
sensitive to cell density because cell-cell interactions affect stem cell differentiation. Thus,
regulation of cell adhesion and control of shape and size of the stem cell monolayer colony are
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very important for maintaining stem cell potential and for inducing these stem cells to
differentiate into specific cells types. In this section, we reviewed the micropatterning tech‐
nology and its application in human iPS cell culture.
2.1. Micropatterning for human ES/iPS cells: difference between human and mouse ES/iPS
cells
Human ES/iPS cells can differentiate all kinds of human body cells [33, 34]. Human ES cells
generated by somatic cell nuclear transfer and human iPS cells contain the donor’s genetic
information. Therefore, ES/iPS cells can be a good source of cells for rejection-free transplan‐
tation of tissues and disease-specific drug screening [34, 35].
Although ES and iPS cells share most of the properties, there are clear differences between
mouse and human ES/iPS cells (Figure 1). Mouse ES/iPS cells can survive after single-cell
dissociation, but human ES/iPS cells undergo apoptosis1 [36] following their single-cell
dissociation. Thus, the culture conditions and adhesion of human ES/iPS cells need to be
carefully controlled to ensure their survival and growth.
Figure 1. Difference between mouse and human ES/iPS cells.
Moreover, there are morphological differences between mouse and human ES/iPS cell
colonies. Mouse ES/iPS cells form spherical aggregates [37–39]and human ES/iPS cells form
flat monolayer colonies [33, 34]. Because the colony size is important for maintaining pluri‐
potency and controlling cell differentiation in ES/iPS cells (see section 3), two-dimensional cell
1 Apoptosis caused by single cell dissociation is partially rescued by adding Y-27632, a selective inhibitor of p160-
Rhoassociated coiled-coil kinase (ROCK).
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patterning is especially important for human ES/iPS cells. Warmflash et al. [40] showed that
the differentiation pattern of human ES/iPS cells depended on the size of monolayer colonies.
In addition, although both mouse and human ES cells are derived from inner cell mass of the
blastocysts, the properties of mouse ES/iPS cells are closer to that of the inner cell mass, while
the properties of human ES/iPS cells are closer to that of epiblast, which is a monolayer of cells
arising from the inner cell mass [41]. The epiblast is functionally and molecularly distinct from
inner cell mass, and is also pluripotent. Thus, micropatterning technology is important,
especially for human ES/iPS cells.
2.2. Micropatterning technology
Although there are many cell micropatterning techniques available [42–47], two important
features need to be considered while applying this technique to human ES/iPS cells. The human
ES/iPS cell differentiation protocols take a few days to few months, and the cell pattern needs
to be long lasting. Although there have been reports of successful patterning of ES/iPS cells,
the cells have been found to escape from the pattern within a few days [43, 46]. The other
feature is ease of pattern preparation. Many micropatterning methods require some special
equipment and techniques that are not easy to perform routinely in cell biology laboratory.
2.3. Micropatterning technology in human ES/iPS cells
We succeeded in forming human iPS cells pattern on the PDMS surface by a simple technique
using plasma2 oxidation with perforated mask and defined culture conditions [48, 49]. As
described above, PDMS is one of the most popular biocompatible materials for research and
development of cell culture microdevices. Plasma treatment on PDMS oxidized ≡Si–CH3
groups to generate ≡Si–O–Si≡ groups suggests that hydrophilic and siliceous layers were
formed on the surface [5, 49].
We first studied the effects of vitronectin and γ-globulin on hiPSC adhesion to plasma-treated
and untreated PDMS surfaces under defined culture conditions [49]. We chose vitronectin and
γ-globulin because they have contrasting properties. Vitronectin as well as fibronectin and
laminin mediate hiPSC attachment, because vitronectin and fibronectin are ligands of integrin
α5β1 and αvβ1, and laminin is a ligand of integrin α6β1 and αvβ5, all of which are known to
be expressed on ES/iPS cells surface [50–53]. Moreover, vitronectin is especially suitable for
coating on glass (≡Si–O–Si≡) [54]. On the other hand, γ-globulin is adsorbed by hydrophobic
surfaces and does not mediate cell adhesion [55]. Immunostaining showed that vitronectin
and γ-globulin were adsorbed on both plasma-treated and plasma-untreated PDMS surfaces
when these proteins were applied separately. However, vitronectin was preferentially
adsorbed on plasma-treated surfaces whereas γ-globulin was adsorbed on untreated surfaces
when the mixture of vitronectin and γ-globulin was applied. Human iPSCs adhered to the
vitronectin-rich plasma-treated surfaces but not to the γ-globulin-rich untreated surfaces.
2 In this chapter, plasma refers to low-pressure plasma, not blood plasma, unless otherwise stated.
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Based on the results, we succeeded in making a monolayer pattern of human iPS cells by using
perforated masks to prepare plasma-patterned PDMS substrates [49]. The patterned human
iPS cells expressed undifferentiated-cell markers and did not escape from the patterned area
for at least 7 days. The patterned PDMS could be stored for up to 6 days before hiPSCs were
plated. Furthermore, we demonstrate that not only γ-globulin but also bovine serum albumin
(BSA) could be used to block human iPS cell adhesion on plasma-untreated PDMS surfaces
(Figure 2) [48]. The hiPSCs proliferated without escaping from the patterned area and finally
detached spontaneously from the discs to form spheroids.
Figure 2. Micropatterned human iPS cells created by plasma patterning of PDMS surfaces and single-step coating of
vitronectin and BSA. (A, B) Perforated PMMA masks. (C) Schematic of the micropatterning procedure. (D–F) Immu‐
nostaining of patterned cells with undifferentiated cells marker anti-SSEA4 (green) and anti-OCT3/4 (red). Nuclei were
stained with DAPI (blue). Lower panels show high magnification images. Reproduced from Yamada et al. [48]with
permission from Begell House.
Our micropatterning method presents four advantages over previously reported methods [42,
56]. (1) The plasma treatment through perforated masks enables equal patterning on a wide
area, therefore a large number of homogeneously patterned cells can be created reproducibly.
(2) Single-step coating of a mixture of proteins is quite simple and easy. Similar methods of
producing cell patterning required additional steps, including multistep protein coatings of
BSA followed by ECM [56]. (3) The cost-effectiveness and availability of γ-globulin, especially
BSA is high. (4) Although there are many types of micro-fabrication tools to make equally sized
spheroids, most of them are expensive and difficult to use in cell culture labs [42]. Our method
is an easy and cost-effective way to fabricate hiPSC discs and spheroids.
2.4. Harvesting micropatterned human ES/iPS cells by controlling divalent cation
Cell sheets such as retinal pigment epithelium and cardiomyocytes derived from human iPS
cells have been developed for applications in regenerative medicine [57, 58]. We tried to har‐
vest micropatterned human ES/iPS cells without their splitting off. Conventionally, cell
sheets are harvested using special equipments, such as a temperature-responsive surface
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and magnet [59, 60]. In contrast, we focused on integrin and cadherin, which are adhesion
molecules on the cell surface. Cadherins mediate cell-cell adhesion at physiological concen‐
tration of Ca2+[61]. On the other hand, integrins mediate cell-ECM adhesion and depend
largely on Mg2+ [62]. Thus, a solution containing physiological concentration of Ca2+, but no
Mg2+, could be used to harvest cells as large cell clumps under serum-free culture condition.
As expected, simple incubation in PBS with Ca2+ without Mg2+ followed by gentle pipetting
enabled us to harvest the cells as sheets without cells splitting off (Figure 3) [63]. Similar re‐
sults were obtained for early-differentiated cells and for hepatic progenitors derived from
human iPS cells. These results suggest that the cells can be routinely and simply harvested
as a large sheet by using a solution with Ca2+and without Mg2+.
Our methods introduced here can be also used practically to mimic epiblast (Figure 1) in early
human embryonic development. We believe that our cell patterning method will be useful for
the development of new bioengineering tools to search for effective cell differentiation
methods and to test drug safety for early human embryonic development.
 
   
f 
Figure 3. Human iPS cells sheet harvesting. (A) Schematics of spot sheet formation and harvest. (B) ALP staining of the
hiPSCs plated on 2-mm-diameter fibronectin spots. Phase-contrast micrographs before (C) and after (D, E) 15 min in
PBS with Ca2+ followed by pipetting. The white arrows indicate the same cellspot sheet (C–E). The red spots in (C, D)
are position makers. Scale bars are 1 cm (B), 1 mm (C–E). (F) Schematics of the effects of Mg2+ and Ca2+ on hPSCs cul‐
ture. Cell-cell and cell-ECM adhesion depend largely on Ca2+ (abscissa) and Mg2+ (ordinate), respectively. Large cell
clumps and sheets can then be harvested by dissociating in lowMg2+ and high Ca2+ solution (lower right).Reproduced
from Ohnuma et al. [63] under a Creative Commons Attribution 3.0 Unported License.
3. Microwell array technology in stem cell culture
The formation of three-dimensional cell aggregates called embryoid bodies (EBs) that resemble
the embryo structure is the principle behind in vitro differentiation of stem cells. Microwell
array is a promising platform for generating EBs, in which microwells of several hundred
micrometers size are regularly fabricated on a culture substratum. It controls EB size and
produces large number of homogenous EBs. An added advantage of microwell array culture
is that it can influence the fate of differentiating cells in EBs. In this section, we review the
architectures of microwell arrays, microwell array culture of ES/iPS cells, and the relationships
between microwell conditions and EB properties.
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3.1. Embryoid body (EB) culture
For in vitro differentiation of stem cells, one of the superior strategies is to imitate in vivo
development processes. Three-dimensional aggregate of stem cells called embryoid body
resembles early embryo. The multicellular interactions generated with the EB formation trigger
cell differentiation. Thus, the EB culture has been used as a principal method for in vitro early
differentiation of stem cells.
The EB is formed by the rearrangement and compaction of stem cell aggregates. Therefore, the
differences in EB sizes affect the diffusion of soluble molecules, the extent of cell-ECM and
cell-cell interactions, and the generation of mechanical forces (Figure 4A).Consequently, it
affects the differentiation and fate of stem cells [64–66]. Thus, the culture technique capable of
modulating EB size is important to regulate stem cell differentiation.
Figure 4. (A) EB characteristics and (B) methods for EB formation.
3.2. Methods for EB formation
The EB formation occurs if cell-cell adhesion is stronger than cell-surface material adhesion.
Therefore, we can lead the EB formation by designing a culture environment, which promotes
cell-cell adhesion. Typical methods for EB formation are hanging drop culture, round-
bottomed 96-well culture, and agitation or rotational culture (Figure 4B) [67, 68]. The agitation
culture can achieve mass production of EBs; however, it is difficult to control the EB size. In
contrast, the hanging drop and round-bottomed 96-well cultures can control the EB size, but
their scale-up is difficult. Furthermore, these methods pose difficulties in handling of the
formed EBs.
Recently, microwell array has been advocated as a promising technique over the current
methods. It is a culture platform in which microwells of several hundred micrometers size are
regularly fabricated on a culture plate (Figure 4B). Recently, various microwell arrays have
been developed by researchers [69]. Generally, the number of microwells is from tens to
thousands per culture plate, and these microwells are laid as triangular or square arrangements
on the plate. The microwells having various shapes such as column, square, and pyramid have
been fabricated by photolithography, soft lithography mold, micromachining, etc. [70–72].
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Furthermore, most microwell arrays are designed with cell nonadhesion surfaces to promote
the EB formation. Such microwell arrays can generate a large number of homogenous EBs,
with controlled size, and allow easy EB handling.
3.3. Our microwell array
We developed a microwell array comprising columnar microwells in triangular arrangement
on a poly-methylmethacrylate (PMMA) plate with the surface modified by polyethylene glycol
(PEG) to render cell nonadhesion (Figure 5A) [73, 74]. This was fabricated as follows (Figure
2B). The microwell structure of array was fabricated using a programmable micromilling
system. Subsequently, the array surface was coated with thin layer of platinum using an ion
sputter unit, and immersed in a PEG-SH solution. The PEG molecule formed covalent
attachment via its thiol group to the platinum layer, thus modifying the surface. The microwell
array manufactured via this process was used for the stem cell culture.
Figure 5C shows the changes in cell morphologies of mouse ES cells within the microwell. The
cells that were seeded on the array began to aggregate within several hours of inoculation, and
they spontaneously formed a single EB in each microwell of array within 1 day of culturing.
Although none of the EBs adhered on the microwell surface, all EBs were held within the
Figure 5. (A) Microwell array, (B) manufacturing processes, (C) EB formation, and (D) culture in the microwell array.
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microwells throughout the culture period. Consequently, the mass production of homogenous
EBs was achieved in the single array (Figure 5D).
3.4. EB properties in the microwell array culture
The microwell array could arbitrarily vary the microwell conditions such as well number,
diameter and depth of well, distance of wells, and cell density. To clarify the characteristics of
microwell array culture, we evaluated the effects of microwell diameter and cell density on
the EB properties of mouse ES cells [75, 76].
Four similar arrays comprising 195 microwells were fabricated with microwell diameters of
400, 600, 800, and 1000 µm to evaluate the relationship between the microwell diameter and
EB property. The hanging drop (HD) culture was used as a control method. In this experiment,
the inoculated cell density was at 1000 cells/well or 1000 cells/drop, and the cells were cultured
in a medium without LIF and inducers.
Figure 6A shows the changes in EB sizes. The EB sizes at the initial stage were almost same
(approximately 150 µm) under all culture conditions. Although the EB in the HD culture grew
drastically with increasing culture time, the growth in the microwell culture was repressed
compared with that in HD culture. Furthermore, the changes in EB sizes depended on the scale
of microwell, and the EB growth in larger microwells was higher than that in smaller micro‐
wells. Figure 6B shows the gene expression levels of hepatic (AFP), cardiac (αMHC), and
vascular (Flk1) differentiation markers. The differentiation fates of EBs were nearly the same
under all conditions, but the gene expression levels varied with culture conditions. The
expressions of differentiation markers were highest in HD culture, and gradually decreased
in 1000, 800, 600, 400 µm arrays in that order. These results indicate that the EB growth and
differentiation rate can be controlled by diameters of microwell, and that they are promoted
in larger microwell conditions. These differences may be attributed to special culture envi‐
ronments provided by the microwell culture. The existence of micro spaces (microwell) might
have facilitated accumulation of various soluble factors which were secreted from the cells.
Additionally, interference effects caused by the neighboring EBs could occur because of
extensive EBs on an array. Consequently, the accumulation of paracrine/autocrine factors and/
or the concentrations of oxygen and nutrients in the culture medium vary by the array
conditions, and the balances of these factors may regulate the EB properties.
To evaluate the relationship between the inoculated cell density and EB property, the cells at
densities of 100, 1000, or 10000 cells/well were inoculated to the array that comprised 195
microwells with 600 µm diameter. Figures 7A and B show the changes in EB sizes and the gene
expression levels of differentiation markers, respectively. The change in the EB size of array
at 100 cells/well was higher than that of array at 1000 cells/well. In contrast, the cells of array
at 10000 cells/well hardly proliferated, and the EB size that formed at the initial stage was
maintained throughout the culture period. The expression levels of differentiation markers
were the smallest in the array at 10000 cells/well. The expression of vascular (Flk1) differen‐
tiation was highest in the array at 100 cells/well, but the array at 1000 cells/well promoted
hepatic (AFP) and cardiac (αMHC) differentiations rather than vascular differentiation,
indicating that the inoculated cell density affects the differentiation fate of EBs. These differ‐
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ences may be caused mainly by the differences in size of EB formed at the initial stage, because
the EB size affects the generation of intercellular interactions which trigger the cell differen‐
tiation. This explanation is also supported by the facts that similar results were also observed
in the HD culture.
Figure 7. (A) Changes in the EB size and (B) the gene expression levels of differentiation markers after 7 days of cul‐
ture.
Figure 6. (A) Changes in the EB sizes and (B) the gene expression levels of differentiation markers after 7 days of cul‐
ture.
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In conclusion, the microwell array culture could control EB size and allow mass production of
homogenous EBs. Furthermore, we demonstrated that differentiation fates of stem cells in the
microwell array culture were similar to previous HD culture, and that the architectures of
microwell array could control the EB growth and differentiation rates. These characteristics
offer advantages over previous methods. Thus, the microwell array may be applicable as a
cellular platform that can control the in vitro properties of EB.
4. Microfluidic perfusion system in stem cell culture
The control over microenvironment is important for controlling the stem cell fate, which is
affected by various soluble factors supplied by the culture medium and by autocrine and
paracrine mechanisms. Microfluidic perfusion enables the control of spatial and temporal
profiles of the concentration of soluble factors. In this section, we review the use of the
microfluidic perfusion culture system, and recent applications of the microfluidic perfusion
culture system in the culture of human ES/iPS cells.
4.1. Microfluidic perfusion culture
Generally, microfluidic perfusion culture in a microfluidic device is carried out using syringe
pumps [77, 78]. However, liquid handling using syringe pumps is cumbersome because it
requires connection of many tubes from syringe pumps to the microfluidic device. To address
this issue, we developed a pressure-driven perfusion culture system, in which multiple liquids
could be handled by simply applying pressure in the liquid reservoir. This is a convenient
system to create different culture conditions in a single microfluidic device [79]. We also
developed a microfluidic network to generate serial dilution concentration profiles using this
pressure-driven perfusion culture system [80].We applied this pressure-driven perfusion
culture system to determine IC50 by using the serial dilution microfluidic network [29]. In these
studies, we developed the perfusion culture microchamber array chip equipped with 12
perfusion culture microchambers. The culture microchambers were connected to a serial
dilution microfluidic network that could generate 12 different stepwise concentration profiles
(Figure 8A). We have successfully applied this pressure-driven microfluidic perfusion culture
system to a dose-response assay of model anticancer drug, paclitaxel. The obtained IC50 of
paclitaxel was similar to that obtained by using traditional microplate assay (Figure 8B).
We have also developed an integrated microfluidic device that contains 384 microchambers
in a single device. (Figure 9) [81]. In this device, 12 different drugs were diluted stepwise in
the serial dilution microfluidic network into eight different concentrations. Each microchannel
for each concentration is connected to four cell culture microchambers (Figure 9B). In total, 384
assays (12 drugs × 8 concentrations ×4 microchambers) could be carried out simultaneously.
The culture media with 12 different drugs, the culture media without drug, and cell suspension
were loaded in the liquid reservoir using a micropipette (Figure 9A). By applying appropriate
pressure, serial dilution concentration profiles spanning 3 orders of magnitude were generated
in six dilution steps. Theoretically, IC50 of 12 drugs could be determined in the single-experi‐
ment setup.
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Figure 9. Microplate-sized integrated perfusion culture microchamber array chip. (A) Photographs of the integrated
perfusion culture microchamber array chip. (B) Enlarged view of a microchamber array unit. Reproduced from Hattori
et al. [81] with permission from CBMS.
Figure 8. Photographs of the perfusion culture microchamber array chip equipped with a serial dilution microfluidic
network. (A) Serial dilution microfluidic network and the cell culture microchambers. (B) Fluorometric cell growth
measurement for drug cytotoxicity assay. Reprinted with permission from Sugiura et al. [29]. Copyright (2010) Ameri‐
can Chemical Society.
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4.2. Microfluidic perfusion system for human iPS cells under defined culture conditions
We tried to control the state of human ES/iPS cell cultures by using microfluidics perfusion
system and defined the culture conditions [82]. Microfluidics perfusion system enables us to
control spatial and temporal application of the soluble factors to the cells. On the other hand,
defined culture conditions enable us to control the kinds of factors that are applied to the cells.
Thus, the combination of microfluidic perfusion system and defined culture conditions enable
us to control microenvironment and replicate stem cells niche in vitro.
Conventional culture methods for human ES/iPS cells use many undefined supplements
including liquid additives such as knockout serum replacement (KSR; Life technologies, Grand
island, NY, USA) and coating matrix such as Matrigel (BD Biosciences, Mississauga, Canada)
[83]. These undefined supplements contain unknown quantity of growth factors, hormones,
and integrin receptors, all of which affect human ES/iPS cells states. Thus, they are not suitable
for being used to control state of human ES/iPS cells. Therefore, culture systems, which consist
of defined supplements including hormones and cytokines and a defined coating matrix such
as fibronectin or laminin, have been developed [84–86]. These defined culture systems enabled
us to assess the direct responses of added factors without masking by undefined factors and
to control differentiation of human ES/iPS cells.
We designed a perfusion culture microchamber array chip that was suitable for ECM coating,
cell loading, and human iPS cells perfusion culture based on our previous reports [30, 79]. In
this system[82], ECM-coating solution and cell suspensions were loaded in all microchambers
through a cell-inlet port (Figure 10A, right) via cell-inlet main channels (Figures 10Band C).
The culture media are supplied from a medium-inlet port (Figure 10A, left) via medium-inlet
main channels (Figures 10B and C). By applying air pressure to these channels, four different
culture conditions can be generated (Figure 10B).
To coat microchambers with purified ECM-coating matrix, we applied two modifications to
our system. First modification was the reduction of medium flow resistance at the medium-
inlet channel3 and the second was intermittent pressure application for medium perfusion.
ECM-coating solution was compulsorily loaded in dried microchambers prior to cell suspen‐
sion loading. Because the flow resistance of the liquid was much higher than that of the air,
this extracoating step decreased the cell loading flow-rate at the same pressure compared with
our previous system, in which the cells were loaded into dried microchambers without an
ECM-coating solution.4 Thus, the medium-inlet channels were modified to be thick to increase
the flow rate of cell suspension, resulting in an increase in the medium perfusion flow rate at
the same pressure. As a result, intermittent pressure was applied during perfusion culture to
keep the average flow rate almost the same as in previous systems. Based on the coating
experiment, we chose fibronectin as ECM for coating microchambers.
3 The medium-inlet branch channel is much more shallow than other microchannels; therefore, the flow rate in each
microchamber is determined by the maximum fluidic resistance of the medium-inlet branch channel.
4 The microchambers were coated unintentionallybecause serum contains ECM such as fibronectin, laminin, and
vitronectin.
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We found that the growth rate of human iPS cells under pressure-driven perfusion culture
conditions was higher than under static culture conditions in the microchamber array. We also
applied our new system to self-renewal and differentiation cultures of human iPS cells.
Immunocytochemical analysis showed that the state of the human iPS cells was successfully
controlled (Figure 9). Moreover, the effects of three antitumor drugs on human iPS cells were
comparable between microchamber array and 96-well plates.
We believe that our system will be a platform technology in future for large-scale screening of
fully defined conditions for differentiation cultures on integrated microfluidic devices.
d 
Figure 10. Structure of the perfusion culture microchamber array chip. (A) Overview of the perfusion culture micro‐
chamber array chip. (B) Enlarged view of the array with four dye solutions. (C) Enlarged view of the microchamber.
(D) Undifferentiated and differentiated human iPS cells in the microchamber array chip. The four lanes of the array
were perfused with four types of defined culture medium: hESF-9a (including a growth factor to keep the cells in un‐
differentiated state), hESF-6 medium (without growth factor), and hESF-6 medium supplemented with 10 ng/mL
BMP4 (+10 BMP) or 50 ng/mL BMP4 (+50 BMP). BMP4 induces early differentiation. Microphotographs were taken at
day 3. PhC: the top panels show phase-contrast micrographs. The lower panels show immunocytochemistry of the
self-renewal marker, Oct 3/4 (red), the early differentiation marker, SSEA1 (green), nuclear staining with DAPI (blue),
and the merged image. The white dotted lines represent the edges of cell culture microchamber. Reproduced from Ya‐
mada et al. [82]with permission from John Wiley and Sons.
5. Summary and perspectives
In this chapter, we introduced the current state of the art of microfabrication technologies used
in stem cell culture. As described above, this technology has already been applied to micro‐
patterning, EB formation, and microfluidic perfusion culture. The microenvironment control‐
led by these microfabrication technologies provided sophisticated culture conditions
compared to that of conventional static monolayer culture. As a result, stem cell cultures could
be carried out in a controlled manner. So far, some obvious advantages of the use of micro‐
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fabrication technology in stem cell culture include control of stem cell fate, easy cultivation
method, and reduction in culture volume.
Although methods discussed achieved certain success to control the culture microenviron‐
ment, the use of microfluidics in human ES/iPS cell studies is still limited [77, 87–91]. For
example, the induction of fully functional organs and the fabrication of complicated 3D
structure mimicking an intact organ is still difficult. Moreover, culture conditions available in
current microfluidic technology are basically limited to conventional 2D cultures. Even
cultivation of cellular aggregate in microfluidic device is still challenging. We believe that these
challenges will be addressed gradually in the future by interdisciplinary approaches including
mechanical engineering, material science, device design, and cell biology.
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